Companies Dominating the Recombinant Proteins Landscape
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Lonza Group AG
- GenScript Biotech Corporation
- AbbVie Inc.
- Amgen Inc.
- Roche Holdings Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Recombinant Proteins Market in 2025 is assessed at USD 2.82 billion.
The global market size was worth around USD 2.55 billion in 2024 and is set to register a CAGR of more than 13%, exceeding USD 12.49 billion revenue by 2037.
North America is likely to approach USD 4.37 billion by 2037, fueled by growing population, cancer diagnosis treatments, and increasing health insurance coverage.
The major players in the market include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, GenScript Biotech Corporation, AbbVie Inc., Amgen Inc., Roche Holdings Inc., Novartis AG, Pfizer Inc., Sanofi SA.
